Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Law Debenture posts strong first-half performance

(Sharecast News) - The Law Debenture Corporation reported a strong first half on Friday, delivering solid returns and continued dividend growth despite a challenging market environment. It posted a net asset value total return of 15.0% for the six months ended 30 June, with debt at both par and fair value, significantly outperforming the FTSE Actuaries All-Share Index's total return of 9.1% over the same period.

The FTSE 250 investment trust said its share price total return for the half-year was 14.2%, more than five percentage points ahead of the benchmark.

Its independent professional services (IPS) division continued its steady growth, with net revenue rising by 7.7% to £28.2m and profit before interest and tax increasing by 7.5% compared with the first half of 2024.

The valuation of the IPS business rose 4.8% to £203.8m from the end of 2024.

"I am pleased with the excellent performance Law Debenture has delivered in the first half of 2025, against a difficult market backdrop," said chairman Robert Hingley.

"The share price total return of 14.2% exceeded our benchmark by over 5% and we are proud that our long-term record of benchmark outperformance remains strong.

"We remain confident that Law Debenture is well-positioned for further growth and to deliver long-term returns for shareholders due to the diversified combination of a high-quality equity portfolio and good growth potential for IPS."Law Debenture's portfolio generated a net capital gain of £132.4m, up from £59.5m a year earlier, while dividend income from the portfolio increased to £22.5m from £19.9m.

The company's ongoing charges ratio was 0.54%, well below the industry average of 1.01%.

It declared a first interim dividend of 8.375p per ordinary share, representing a 4.7% increase on the prior year's first interim dividend, and reaffirmed its policy of maintaining or increasing total dividends in 2025.

Based on the 24 July closing share price of 995p, Law Debenture's dividend yield stood at 3.4%.

During the first half, the company issued 1.3 million new shares at a premium to NAV, raising £11.6m.

"Law Debenture has once again demonstrated its resilience and ability to adapt against a backdrop of elevated market turbulence and continued macroeconomic uncertainty," commented chief executive Denis Jackson.

"Our unique combination of IPS with the investment portfolio has meant we have been able to navigate these headwinds and continue delivering outperformance of our benchmark.

"I am confident that our well-diversified structure means we are capable of continuing to create value for our shareholders over the long-term."

Over longer time horizons, Law Debenture said its performance remained well ahead of the FTSE All-Share Index, with NAV total return of 52.2% over three years and 120.4% over five years, compared with benchmark returns of 35.5% and 67.3% respectively.

The share price total return over 10 years stood at 187.5%, double the FTSE All-Share's 92.7%.

At 1235 BST, shares in the Law Debenture Corporation were up 0.21% at 997.12p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.